Pretreatment of therapeutic cells with poly(ADP-ribose) polymerase inhibitor enhances their efficacy in an in vitro model of cell-based therapy in myocardial infarct

The potential of cell-based therapies in diseases involving ischemia-reperfusion is greatly hampered by the excessive loss of administered cells in the harsh and oxidative environment where these cells are supposed to act. Therefore, we investigated if inhibition of poly(ADP-ribose) polymerase (PARP...

Descripción completa

Detalles Bibliográficos
Autores principales: SZEPES, MÓNIKA, JANICSEK, ZSÓFIA, BENKŐ, ZSOLT, CSELENYÁK, ATTILA, KISS, LEVENTE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573747/
https://www.ncbi.nlm.nih.gov/pubmed/23165319
http://dx.doi.org/10.3892/ijmm.2012.1186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573747/
https://www.ncbi.nlm.nih.gov/pubmed/23165319
http://dx.doi.org/10.3892/ijmm.2012.1186

Ejemplares similares